The Licensing Agreement In Pharmaceutical Business Development 3Rd Edition

In addition to the updated report, you will also receive a series of model contracts, including a disposable confidentiality agreement, a feasibility agreement, and a checklist for a development and licensing agreement. The virtual business model is also extremely useful for determining the terms of co-development agreements. For example, imagine that Company B is interested in developing a project currently owned by Company A. It is planned to license it together with a pharmaceutical partner according to Proof of Concept in humans. In the virtual business model, we can then expect both companies to contribute to each capital increase, i.e. both companies to finance the development. These contributions must be designed in such a way that Company B has acquired a 50% stake in NewCo by Phase II at the latest. . . .

Comments are closed.